| Record ID | marc_nuls/NULS_PHC_180925.mrc:6159796:1752 |
| Source | marc_nuls |
| Download Link | /show-records/marc_nuls/NULS_PHC_180925.mrc:6159796:1752?format=raw |
LEADER: 01752cam 2200313 a 4500
001 9921198910001661
005 20150423133635.0
008 951120s1996 nyua b 001 0 eng c
010 $a 95043353
020 $a0684827379 (hc)
029 1 $aNLM$b9517940
035 $a(CSdNU)u59707-01national_inst
035 $a(OCoLC)33838225
035 $a(Sirsi) 01-AAG-3841
040 $aDNLM/DLC$cDLC$dNLM$dC#P
049 $aCNUM
050 00 $aRC483$b.G55 1996
100 1 $aGitlin, Michael J.
245 14 $aThe psychotherapist's guide to psychopharmacology /$cMichael J. Gitlin.
250 $a2nd ed.
260 $aNew York :$bFree Press,$cc1996.
300 $axxiv, 534 p. :$bill. ;$c25 cm.
504 $aIncludes bibliographical references (p. 473-508) and index.
505 0 $a Diagnosis and treatment: basic principles -- Biological basis of psychopharmacology -- Mood disorders -- Anxiety disorders and insomnia -- Schizophrenia and related disorders -- Disorders of impulse control: eating disorders, drug and alcohol abuse, and adult attention deficit/hyperactivity disorders (ADHD) -- Personality disorders -- Treatment of special populations: children/adolescents, the elderly, and women -- Antidepressants -- Lithium and other mood stabilizers -- Antianxiety medications and hypnotics -- Antipsychotics -- Electroconvulsive therapy (ECT); stimulants -- The split treatment model: interactions between psychotherapy and pharmacotherapy.
650 0 $aMental illness$xChemotherapy.
650 0 $aPsychotropic drugs.
650 0 $aPsychopharmacology.
948 $a10/13/1999$b10/13/1999
999 $aRC 483 G55 1996$wLC$c1$i31786100892501$d5/22/2008$e6/7/2005 $f5/13/2004$g1$lCIRCSTACKS$mNULS$n6$q1$rY$sY$tBOOK$u7/16/1997$o.STAFF. Pieces: 00001